Pre-Transplant Azacitidine and Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes of One Hundred Fifty-Nine Patients up to Age Seventy-Five with Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

✍ Scribed by Field, Teresa; Perkins, Janelle; Hillgruber, Ryan; Nishihori, Taiga; Tomblyn, Marcie R.; Mishra, Asmita; Pidala, Joseph; Locke, Frederick; Perez, Lia Elena; Betts, Brian; Ayala, Ernesto; Alsina, Melissa; Ochoa, Jose-Leonel; Padron, Eric; Lancet, Jeffery; Fernandez, Hugo; List, Alan F.; Komrokji, Rami; Kharfan-Dabaja, Mohamed; Anasetti, Claudio

• Book ID: 122203719
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 71 KB
• Volume: 20
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2013.12.374